Liposomes/chitosan scaffold/human fibrin gel composite systems for delivering hydrophilic drugs - Release behaviors of Tirofiban in vitro

Drug Delivery

Volumn 15, Issue 3, 2008, Pages 149-157

  Wang, Shoi Shen ^a   Yang, Min Chia ^b   Chung, Tze Wen ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^c NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Chitosan Scaffolds; Depot Drug Delivery System; Fibrin Gels; Liposomes; Sustained Release

Indexed keywords

ADENOSINE DIPHOSPHATE; CHITOSAN; FIBRIN; GLUTARALDEHYDE; LIPOSOME; OCTADECYLAMINE; TIROFIBAN;

ARTICLE; CROSS LINKING; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; GEL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ALGORITHMS; CHITOSAN; CROSS-LINKING REAGENTS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROSTATICS; FIBRIN; FIBRINOLYTIC AGENTS; GELS; GLUTARAL; HUMANS; LIPOSOMES; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR WEIGHT; PARTICLE SIZE; POROSITY; SOLUBILITY; TIME FACTORS; TYROSINE;

EID: 41549150396     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540801952456     Document Type: Article

References (28)

1. Allen, M., Hansen, C., Martin, F., Redemann, C., and Young, A. Y. 1991. Liposome containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochem. Biophs. Acta 1066:29-36.
2. Bergquist, P. A., Manas, D., Hunke, W. A., and Reed, R. A. 2001. Stability and compatibility of Tirofiban hydrochloride during simulated Y-site administration with other drugs. Am. J. Health. Syst. Pharm. 58:1218-1223.
3. Blanco, D., and Alonso, M. J. 1998. Protein encapsulation and release from poly (lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 45:285-294.
4. Castile, J. D., and Taylor, K. M. G. 1999. Factors affecting the size distribution of liposomes produced by freeze-thaw extrusion.Int. J. Pharm. 188:87-95.
5. Chapman, C. J., Erdahl, W. L., Taylor, R. W., and Pfeiffer, D. R. 1990. Factor affecting solute entrapment in phospholipid vesicles prepared by the freeze-thaw extrusion method: a possible general method for improving the efficiency of entrapment. Chem. Phys. Lipids 55:73-83.
6. Chung, T.W., Huang, Y. Y., Tsai, Y. L., and Liu, Y. Z. 2002a. Effects of solvent evaporation rate on the properties of protein-loaded PLLA and PDLLA microspheres fabricated by emulsion-solvent evaporation process. J. Microencap. 19:463-471.
7. Chung, T. W., Tyan, Y. C., Hsieh, J. H., Wang, S. S., and Chu, S. H. 2002b. Shear stress-induced aggregation of oxidized platelets. Thromb Res. 105:325-329.
8. Chung, T. W., Lu, Y. F., Wang, S. S., Lin, Y. S., and Chu, S. H. 2003. Growth of human endothelial cells on the photochemically grafted Gly-Arg-Gly-Asp (GRGD) chitosans. Biomaterials. 23:4803-4809.
9. Chung, T. W., Yang, M. G., and Tsai, W. J. 2006. A fibrin encapsulated liposomes- in-chitosan matrix (FLCM) for delivering water-soluble drugs, Influences of the surface properties of liposomes and crosslinked fibrin network. Int. J. Pharm. 311:122-129.
10. Cohen, S., Yoshioka, T., Lucarrelli, M., Hwang, L. H., and Langer, R. 1991. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8:713-720.
11. Ho, H. O., Hsiao, C. C., Chen, C. Y., Sokoloski, T. D., and Sheu, M. T. 1994. Fibrin-based drug delivery systems, II. The preparation and characterization of micro-beads. Drug. Dev. Ind. Pharm. 20:535-546.
12. 2-plasmin inhibitor to fibrin. FEBS Lett. 152:369-371.
13. Madihally, S. V., and Matthew, H. W. T. 1999. Porous chitosan scaffolds for tissue engineering. Biomaterials. 20:1133-1142.
14. Maes, M., Planken, M. V., Gastel, A. V., and Desnyder, R. 1996 Blood coagulation and platelet aggregation in major depression. J. Affect. Disord. 40:35-40.
15. Manning, M. C., Patel, K., and Borchardt, R.T. 1989. Stability of protein pharmaceuticals. Pharm. Res. 6:903-918.
16. Meyenburg, S., Lilie, H., Panzner, S., and Rudolph, R. 2000. Fibrin encapsulated liposomes as protein delivery system studies on the in vitro release behavior. J. Contr. Rel. 69:159-168.
17. Moribe, K., Maruyama, K., and Iwatsuru, M. 1999. Molecular localization and state of amphotericin B in PEG liposomes.Int. J. Pharm. 193:97-106.
18. Park, S. H., Park, S. R., Chung, S. I., Pai, K. S., and Min, B. H. 2005. Tissue-engineering cartilage using fibrin / hyaluronan composite gel and its in vivo implantation. Artif. Organs. 29: 838-845.
19. Prism-Plus Investigators. 1998. Inhibition of the platelet glycoprotein IIb/IIIa receptor: inhibition with Tirofiban in unstable angina and non-Q-wave myocardial infarction. N. Engl. J. Med. 38:1488-1497.
20. Restore Investigators. 1997. Effects of platelet glycoprotein IIb/ IIIa blockade with Tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 96:1445-1453.
21. Sakiyama-Elbert, S., and Hubbell, J. 2000. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Contr. Rel. 65:389-402.
22. Sandor, M., Riechel, A. I., Kaplan, A., and Mathiowitz, E. 2002. Effect of Lecithin and MgCO3 as additives on the enzymatic activity of carbonic anhydrase encapsulated in poly (lactide-co-glycolide) (PLGA) microspheres. Biochim. Biophys. Acta. 1570:63-74.
23. Schense, J. C., and Hubbell, J. A. 1999. Cross-linking exogenous bifunctional peptides into fibrin gels Factor XIIIa. Bioconj. Chem. 10:75-81.
24. Shu, X. Z., Zhu, K. J., and Song,W. 2001.Novel pH-sensitive citrate cross-linked chitosan film for drug release. Int. J. Pharm. 212:19-28.
25. Tabata, Y., Gutta, S., and Langer, S. 1993. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm. Res. 10:487-496.
26. Takeuchi, H., Kojima, H., Yamamoto, H., and Kawashima, Y. 2001. Evaluation of circulation profiles of liposomes coated with water-soluble polymers having different molecular weights in rats. J. Contr. Rel. 75:83-91.
27. Yang, M. G. Master Thesis, 2003. Porous Chitosan Membrane for Controlled Drug Release from a Liposome/Fibrin System. Dept. of Biomedical Engineering, Chung-Yuan Christian University, Chung Li. Taiwan, ROC.
28. Ye, Q., Zund, G., Benedikt, P., Jockennoevel, S., Hoerstrup, S. P., Sakyama, S., Hubbell, J. A., and Turina, M. 2000. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiothor. Surg. 17:587-591.